Results 151 to 160 of about 4,593,278 (410)

Initial experience of dedicated breast PET imaging of ER+ breast cancers using [F-18]fluoroestradiol. [PDF]

, 2019
Dedicated breast positron emission tomography (dbPET) is an emerging technology with high sensitivity and spatial resolution that enables detection of sub-centimeter lesions and depiction of intratumoral heterogeneity.
Chien, Amy J, Esserman, Laura J, Franc, Benjamin L, Hylton, Nola M, Joe, Bonnie N, Jones, Ella F, Li, Wen, Mukhtar, Rita A, Pampaloni, Miguel H, Ray, Kimberly M, Seo, Youngho   +10 more
core   +2 more sources

A multicenter randomized controlled trial evaluating the effect of the use of an anti‐adhesion barrier for diverting ileostomy on the multidimensional workload in minimally invasive surgery for rectal cancer (YCOG 2005: The ADOBARRIER study)

Annals of Gastroenterological Surgery, EarlyView.
This multicenter, single‐blind, randomized, controlled trial was conducted to evaluate the multidimensional workload of the first operator during ileostomy closure using the SURG‐TLX between groups with and without the use of the spray‐type anti‐adhesion material during diverting ileostomy construction.
Emi Ota, Jun Watanabe, Yusuke Suwa, Masakatsu Numata, Hirokazu Suwa, Hiroki Ohya, Kazuya Nakagawa, Mayumi Ozawa, Itaru Endo   +8 more
wiley   +1 more source

Perioperative chemotherapy in colorectal cancer with peritoneal metastases: A global propensity score matched studyResearch in context

EClinicalMedicine, 2023
Summary: Background: There is a paucity of studies evaluating perioperative systemic chemotherapy in conjunction with cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with colorectal cancer peritoneal ...
Peter H. Cashin, Jesus Esquivel, Stein G. Larsen, Winston Liauw, Nayef A. Alzahrani, David L. Morris, Vahan Kepenekian, Isabelle Sourrouille, Frédéric Dumont, Jean-Jacques Tuech, Cécilia Ceribelli, Beranger Doussot, Olivia Sgarbura, Francois Quenet, Olivier Glehen, Oliver M. Fisher   +15 more
doaj  

Genomic and transcriptomic determinants of response to neoadjuvant therapy in rectal cancer

Nature Network Boston, 2022
Walid K. Chatila, Jin K. Kim, H. Walch, Michael R. Marco, Ching-Tung Chen, Fan Wu, D. Omer, D. Khalil, K. Ganesh, X. Qu, A. Luthra, Seo-Hyun Choi, Yu-jui Ho, Ritika Kundra, Katharine I Groves, O. Chow, A. Cercek, M. Weiser, M. Widmar, I. Wei, E. Pappou, G. Nash, P. Paty, Q. Shi, E. Vakiani, S. Duygu Selcuklu, M. Donoghue, D. Solit, M. Berger, J. Shia, Raphael A. Pelossof, P. Romesser, R. Yaeger, J. Smith, N. Schultz, F. Sánchez-Vega, J. García-Aguilar   +36 more
semanticscholar   +1 more source

Post-Neoadjuvant Therapy [PDF]

Breast Care, 2019
Michael Untch, Andreas Schneeweiss, David Krug, Thorsten Kühn, Sibylle Loibl   +4 more
openaire   +3 more sources

Short‐ and Long‐Term Outcomes of Open, Laparoscopic, and Robot‐Assisted Surgery for Rectal Cancer

Annals of Gastroenterological Surgery, EarlyView.
Robot‐assisted rectal resection demonstrated superior short and long‐term outcomes compared to laparoscopic and open approaches. ABSTRACT Background Robot‐assisted surgery has short‐term benefits in rectal cancer surgery; however, its long‐term advantages remain unclear. This study compared short‐ and long‐term outcomes of open, laparoscopic, and robot‐
Marie Hanaoka, Hiroyasu Kagawa, Ataru Igarashi, Hiroshi Yoshihara, Shinichi Yamauchi, Masanori Tokunaga, Lin Peng‐Lin, Minkyung Shin, Yusuke Kinugasa   +8 more
wiley   +1 more source

Challenges in constructing genetic instruments for pharmacologic therapies [PDF]

arXiv, 2020
The genes that encode the targets of most therapies do not have rare variants with large-effect or common variants with moderate effects on the biomarker reflecting the pharmacologic action of the corresponding therapy. Therefore, providing genetic target validation for most therapies is challenging.
arxiv  

Inflammatory fibroblasts mediate resistance to neoadjuvant therapy in rectal cancer.

Cancer Cell, 2022
Adele M. Nicolas, M. Pesic, Esther Engel, Paul K Ziegler, M. Diefenhardt, Kilian B. Kennel, F. Buettner, Claire Conche, V. Petrocelli, Eiman Elwakeel, A. Weigert, A. Zinoveva, Maximilian Fleischmann, Björn Häupl, Cem Karakütük, H. Bohnenberger, Mohammed H. Mosa, L. Kaderali, J. Gaedcke, M. Ghadimi, F. Rödel, M. C. Arkan, T. Oellerich, C. Rödel, E. Fokas, F. Greten   +25 more
semanticscholar   +1 more source

Improved Axillary Evaluation Following Neoadjuvant Therapy for Patients With Node-Positive Breast Cancer Using Selective Evaluation of Clipped Nodes: Implementation of Targeted Axillary Dissection.

Journal of Clinical Oncology, 2016
PURPOSE Placing clips in nodes with biopsy-confirmed metastasis before initiating neoadjuvant therapy allows for evaluation of response in breast cancer.
A. Caudle, W. Yang, S. Krishnamurthy, E. Mittendorf, Dalliah M. Black, M. Gilcrease, I. Bedrosian, B. Hobbs, S. DeSnyder, R. Hwang, B. Adrada, S. Shaitelman, M. Chávez-MacGregor, Benjamin D. Smith, R. Candelaria, G. Babiera, B. Dogan, L. Santiago, K. Hunt, H. Kuerer   +19 more
semanticscholar   +1 more source

Endoscopic ultrasound in the staging of gastrointestinal luminal malignancies [PDF]

, 2013
Endoscopic ultrasound (EUS) is an important tool in the staging of gastrointestinal cancers. This review highlights the use of EUS in the staging of gastrointestinal luminal malignancies and compares the performance of EUS with other imaging modalities ...
Azzopardi, Neville
core